HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limited auricular relapsing polychondritis in a child treated successfully with infliximab.

Abstract
Relapsing polychondritis (RP) is a rare progressive and destructive multisystem disorder characterised by recurrent inflammation of cartilaginous structures. It is a rare disease in paediatrics compared with adults. In children, the diagnosis is either delayed or overlooked due to low incidence. Auricular chondritis has been described in more than half of paediatric cases with RP. However, isolated auricular chondritis has not been reported as the only presentation of pediatric-onset RP. We described a lad who presented with isolated auricular chondritis, which is refractory to conventional treatment, including glucocorticoids and methotrexate as steroid-sparing agent. Remission of his disease's relapses was sustained with infliximab. Limited auricular involvement as a presenting feature of RP in the absence of systemic association is very rare in children. We describe a case of successful use of infliximab on limited auricular chondritis disease.
AuthorsJubran Theeb Alqanatish, Basma Ali Alfarhan, Sara Mohammed Qubaiban
JournalBMJ case reports (BMJ Case Rep) Vol. 12 Issue 5 (May 23 2019) ISSN: 1757-790X [Electronic] England
PMID31126928 (Publication Type: Case Reports, Journal Article)
Copyright© BMJ Publishing Group Limited 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Chemical References
  • Antirheumatic Agents
  • Infliximab
Topics
  • Adolescent
  • Antirheumatic Agents (administration & dosage, therapeutic use)
  • Diagnosis, Differential
  • Ear Auricle
  • Humans
  • Infliximab (administration & dosage, therapeutic use)
  • Male
  • Polychondritis, Relapsing (diagnosis, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: